Detalhe da pesquisa
1.
Evaluation of the usefulness of protocol-based pharmacist-facilitated laboratory monitoring to ensure the safety of immune checkpoint inhibitors in patients with lung cancer.
J Clin Pharm Ther
; 45(6): 1288-1294, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32519774